Ardana Plc Release: Interim Management Statement Three Months Ended 31 December 2007
Published: Feb 19, 2008
Edinburgh, UK, February 19, 2008: Ardana plc (LSE:ARA), the emerging pharmaceutical company focused on the discovery, development and marketing of innovative products to improve human reproductive health, is today issuing its third quarter Interim Management Statement (“IMS”) and provides an update on the business. This IMS has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority’s Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.